Roxatidine acetate is an H2-receptor antagonist used to treat and prevent gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome by reducing gastric acid secretion. It works by blocking histamine’s effect on stomach parietal cells, leading to a dose-dependent decrease in acid production. It also has potential applications in treating erosive esophagitis, gastritis, and as a premedication before anesthesia, and has shown some effects in reducing inflammation and promoting ulcer healing. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pifatidine, Roxane and Aceroxatidine. Its PubChem CID is 5105.
Roxatidine acetate
| CAS No | 78628-28-1 |
|---|---|
| Molecular Formula | C19H28N2O4 |
| Molecular Weight | 348.4 g/mol |
| Synonyms | [2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Roxatidine acetate is an H2-receptor antagonist used to treat and prevent gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome by reducing gastric acid secretion.
The listed CAS number is 78628-28-1.
The listed molecular formula is C19H28N2O4.
The listed molecular weight is 348.4 g/mol.
[2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate.
The source lists Pifatidine, Roxane and Aceroxatidine.